首页> 外文OA文献 >Retraction notice to “30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)”

【2h】

Retraction notice to “30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)”

机译：撤回通知“30MO东方 - 3：一系列随机的，开放标签，Sintilimab的第III阶段研究与先前治疗的先进/转移性鳞状非小细胞肺癌（SQNSCLC）”

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Y. Shi; L. Wu; X. Yu; P. Xing; J. Zhou; A. Wang; J. Shi; Y. Hu; Z. Wang; G. An; Y. Fang; S. Sun; C. Zhou; C. Wang; F. Ye; X. Li; J. Wang; M. Wang; Y. Liu; Y. Zhao;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. [J] . Fossella FV, DeVore R, Kerr RN, Journal of Clinical Oncology . 2000,第12期

机译：多西他赛与长春瑞滨或异环磷酰胺在之前接受过含铂化疗方案治疗的晚期非小细胞肺癌患者中的随机III期试验。 TAX 320非小细胞肺癌研究组。
2. A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer [J] . Athanasios G Pallis, Sophia Agelaki, Athina Agelidou, BMC Cancer . 2010,第1期

机译：多西他赛/卡铂联合与多西他赛单药作为二线治疗晚期/转移性非小细胞肺癌患者的随机III期研究
3. Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer who have previously received platinum-based chemother [J] . J.Y. Douillard, . E.S. Kim, V Hirsh, European Journal of Cancer Supplements . 2007,第6期

机译：口服吉非替尼（IRESSA）与静注多西紫杉醇治疗局部晚期或转移性非小细胞肺癌的先前接受铂类化学疗法的患者的III期随机，开放标签，平行分组研究
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study CTONG-0904): an open-label randomized phase III trial [O] . Li Zhang, Shun Lu, Ying Cheng, 2021

机译：多西紫杉醇维护治疗与不同剂量DOCETAXEL加顺铂的先进非小细胞肺癌（TFINE-0904）：开放标签随机第三阶段试验
7. PRS-02: Gefitinib (IRESSA) versus docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer pre-treated with platinum-based chemotherapy: a randomized, open-label Phase III study (INTEREST) [O] . Douillard Jean-Yves, Kim Edward, Hirsh Vera, 2007

机译：PRS-02：吉非替尼（IRESSA）与多西紫杉醇联合铂类化学疗法治疗的局部晚期或转移性非小细胞肺癌患者：一项随机，开放标签的III期研究（INTEREST）

Retraction notice to “30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)”

著录项

引文网络

相似文献

相关主题

期刊订阅